PHARMCUBE

Serial Number 88502684
Registration 6375538
700

Registration Progress

Application Filed
Jul 7, 2019
Under Examination
Approved for Publication
Nov 10, 2020
Published for Opposition
Nov 10, 2020
Registered
Jun 8, 2021

Trademark Image

PHARMCUBE

Basic Information

Serial Number
88502684
Registration Number
6375538
Filing Date
July 7, 2019
Registration Date
June 8, 2021
Published for Opposition
November 10, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 8, 2021
Registration
Registered
Classes
036

Rights Holder

PHARMCUBE GROUP CO., LTD.

16
Address
F3, BLOCK 1, NO. 400 FANGCHUN ROAD
SHANGHAI PILOT FREE TRADE ZONE
SHANGHAI 201210
CN

Ownership History

Beijing Pharmcube Technology Limited

Original Applicant
16
Beijing CN

Beijing Pharmcube Technology Limited

Owner at Publication
16
Beijing CN

Beijing Pharmcube Technology Limited

Original Registrant
16
Beijing CN

PHARMCUBE (BEIJING) CO., LTD.

New Owner After Registration #1
16
BEIJING CN

PHARMCUBE GROUP CO., LTD.

New Owner After Registration #2
16
SHANGHAI CN

Legal Representation

Attorney
Gloria Tsui-Yip

USPTO Deadlines

Next Deadline
503 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210608)
Due Date
June 08, 2027
Grace Period Ends
December 08, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Sep 5, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 19, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Feb 8, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 8, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 8, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 8, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 6, 2021 CHPB I CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Loading...
May 6, 2021 APET A ASSIGNED TO PETITION STAFF Loading...
Mar 21, 2021 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Feb 10, 2021 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Dec 10, 2020 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Nov 10, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 10, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 21, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 6, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 1, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 1, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 1, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 24, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 24, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Apr 24, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 31, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 30, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 30, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 1, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 1, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 1, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 24, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 15, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 10, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 036
Investment consultation in the field of medical devices, pharmaceuticals, health care and life sciences; Financial investment brokerage services in the field of medical devices, pharmaceuticals, health care and life sciences; Financial information provided by electronic means in the field of medical devices, pharmaceuticals and life sciences; Fund investment consultation in the field of medical devices, pharmaceuticals, health care and life sciences; Mutual fund investment in the field of medical devices, pharmaceuticals, health care and life sciences; mutual funds and capital investment in the field of medical devices, pharmaceuticals, health care and life sciences

Additional Information

Pseudo Mark
PHARMACEUTICALS CUBE

Classification

International Classes
036